Search

We speak with the Alzheimer’s Society in the UK about their work. Find out more with The Medicine Maker

An expert from Samsung Biologics offers her perspective on the future of antibody drug conjugates.

Software development and CDMO experts share their key tips for choosing the right digital technologies and partnerships

NervGen President and CEO Mike Kelly discusses the potential of the company’s investigational drug NVG-291 for spinal cord injury.

We dive into the archive of 2021 for insight and inspiration – this time with Sandy Macrae.

Check out our video interview with Debra Weiss from the Bill & Melinda Gates Medical Research Institute.

The transportation, storage, and administration of drugs in space: a hypothesis and the case for lyophilization

We dive into the archive of 2020 for insight and inspiration – this time with Anne Phelan.

Technology developers at Ghent University developed a spin freeze-drying process for continuous processing.

An interview on the development of Amtagvi – the world’s first approved T-cell therapy for a solid tumor.